A PROSPECTIVE STUDY OF MULTIDRUG RESISTANCE AND A PILOT STUDY OF THE SAFETY OF AND CLINICAL AND MICROBIOLOGIC RESPONSE TO LEVOFLOXACIN IN COMBINATION WITH OTHER ANTIMYCOBACTERIAL DRUGS FOR TREATMENT OF MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS (MDRTB) IN HIV-INFECTED PATIENTS.: